(RTTNews) – Eli Lilly and Company (LLY) and Incyte Corp. (INCY) Friday announced that data from eight Olumiant clinical trials using baricitinib in moderate-to-severe rheumatoid arthritis yielded similar results with placebo-treated patients. At presentations at the Annual European Congress of….
Posted: 2017-06-16 12:01:00